Published price vs quote-only
MedVi vs Wellorithm: Which One Publishes Its Price? (2026)
MedVi $299/mo vs Wellorithm quotes after intake. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
On paper, MedVi and Wellorithm sell the same thing: a prescription, a vial and a delivery date. In practice they are priced and staffed on different assumptions.
MedVi publishes what it charges — $179 promotional first month. Wellorithm does not: pricing is not published; you receive a quote only after completing the intake quiz. That asymmetry is the comparison, because you can only price-check one of these two before handing over a medical history.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Easier to price in advance
- MedVi — $179 promotional first month. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most support for the money
- Wellorithm — Virtual consultations with licensed clinicians.
- Fastest route to a first shipment
- Wellorithm — 2-minute eligibility quiz, then medication shipped to your home.
- Longest public track record
- MedVi — 12,896 patient reviews against 3,240.
The short version: MedVi vs Wellorithm
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| MedVi | Wellorithm | |
|---|---|---|
| Advertised price | $179 promotional first month | Priced after the eligibility quiz |
| Rate after promotions | $299/mo | not published before intake |
| Pricing structure | Promotional first month, then standard rate | Quoted only after intake |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Published upfront | Quote only, after intake |
| How fast you start | Simple online process, no clinic visits | 2-minute eligibility quiz |
| Membership fee | None | Not stated |
| State coverage | Not published | All 50 states |
| Support model | No coaching program stated | No coaching program stated |
| Patient reviews | 12,896 | 3,240 |
| eRxDoctor score | 9.2/10 | 7.5/10 |
MedVi vs Wellorithm on total cost, not entry price
A first-month price is a customer-acquisition number. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| MedVi | Wellorithm | |
|---|---|---|
| First month | $179 | Not published |
| Months 2 onward | $299/mo | Not published |
| 6-month total | $1,674 | Not computable |
| 12-month total | $3,468 | Not computable |
| Best published plan | 3-month plan at $649 — $2,592/yr | No multi-month discount published |
A like-for-like annual total is not available for Wellorithm: pricing is not published; you receive a quote only after completing the intake quiz. Treat any comparison that quotes one as an estimate someone else has made for you.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
What you know before you hand over a medical history
MedVi states its terms upfront: $179 promotional first month, promotional first month, then standard rate. You can decide whether it fits your budget without giving anyone a medical history.
Wellorithm runs the other way around — pricing is not published; you receive a quote only after completing the intake quiz. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
The workaround is straightforward: complete Wellorithm's assessment, get the quote, and then price it against MedVi's published $299/mo before agreeing to anything.
How MedVi works
MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
Intake is simple online process, no clinic visits. Fulfillment is fast, free shipping. The commercial terms are promotional first month, then standard rate, published upfront.
Behind the prescription sits 24/7 support from certified medical professionals. Available medication: compounded semaglutide.
MedVi pros
- Simple online process with no clinic visits required
- 24/7 support from certified medical professionals
- Clinically dosed compounded semaglutide
- Low promotional first month at $179 including fast, free shipping
MedVi cons
- Compounded medication only, no branded Ozempic or Wegovy
- No published outcome or weight loss guarantee
- Price increases sharply after the first month, $299 for a standalone month
Read next to Wellorithm, the weak point: the price roughly doubles to $299 once the promotional month ends.
Wellorithm: what you are buying
The pitch is licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin. Take the 2-Minute Quiz to Check Your Eligibility
Getting started means 2-minute eligibility quiz, after which medication shipped to your home. Pricing runs on a quoted only after intake basis, quote only, after intake.
Ongoing care is virtual consultations with licensed clinicians, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Wellorithm pros
- Fully virtual consultations with medication shipped to your home
- No insurance pre-authorization required
- Licensed clinicians in all 50 states, broader coverage than many smaller platforms
- Both compounded semaglutide and tirzepatide available
Wellorithm cons
- Smaller, less-established platform with limited public reviews
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Pricing is not published, you only get a quote after completing the intake quiz
Where it gives ground to MedVi: a smaller platform with no published price and limited public review volume.
Picking between them
Choose MedVi if:
- you want to start on their timeline: simple online process, no clinic visits
- delivery works the way you want it to: fast, free shipping
- you want the full price in front of you before completing an intake
- you are willing to commit for a term in exchange for a lower effective rate (3-month plan at $649)
Choose Wellorithm if:
- you are in a state where GLP-1 telehealth coverage is patchy
- you would get real value from licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin
- the level of clinical contact suits you: virtual consultations with licensed clinicians
- you want to start on their timeline: 2-minute eligibility quiz
What each one gives up
On price. Only MedVi publishes a rate you can plan against ($179 promotional first month). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On medication. MedVi covers compounded semaglutide; Wellorithm covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
On clinical contact. 24/7 support from certified medical professionals at MedVi; virtual consultations with licensed clinicians at Wellorithm. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
What the trials and the FDA say
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
MedVi vs Wellorithm: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
How much does Wellorithm cost?
Pricing is not published; you receive a quote only after completing the intake quiz. That is the honest answer, and it is the main practical drawback next to MedVi, which publishes $179 promotional first month upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Which is cheaper to start, MedVi or Wellorithm?
Only MedVi publishes a first-month figure ($179 promotional first month). The other quotes after intake, so a starting-cost comparison is not available in advance.
How fast can I start with MedVi compared with Wellorithm?
MedVi advertises simple online process, no clinic visits, with fast, free shipping. Wellorithm advertises 2-minute eligibility quiz, with medication shipped to your home. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Are MedVi and Wellorithm legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. MedVi operates on promotional first month, then standard rate with pricing published upfront, Wellorithm on quoted only after intake, quote only, after intake. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both MedVi and Wellorithm price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. MedVi leads on a genuinely low promotional entry point with 24/7 clinical support behind it; Wellorithm leads on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Get the maintenance-dose price in writing from whichever one you pick. That single question prevents most of the regret in this category.
Keep comparing
- TrimRx vs MedViBudget vs premium
- Yucca Health vs MedViBudget vs premium
- Wellorithm vs MaximusPublished price vs quote-only
- Wellorithm vs He & She MDPublished price vs quote-only
- Yucca Health vs DirectmedsPublished price vs quote-only
- JoinFridays vs DirectmedsPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or Wellorithm, and does not sell treatment. Read our ranking methodology.